The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
-
expand
Dapagliflozin Effect on Cardiovascular Events
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
- Study Id
- D1693C00001
- Disease
- myocardial infarction
- Drug Name
- dapagliflozin
- Study Name
- D1693C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Long-term follow-up of antithrombotic management patterns in Acute Coronary Syndrome patients
- Study Id
- NIS-CEU-DUM-2009/1
- Disease
- acute coronary syndrome
- Drug Name
- non drug study (cardiovascular)
- Study Name
- NIS-CEU-DUM-2009/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patients with Coronary Heart Disease: A Randomized, Open Label, Crossover Study
- Study Id
- D5130C00078
- Disease
- coronary blood flow
- Drug Name
- Brilinta
- Study Name
- D5130C00078
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Single-centre, Randomized, Open-label, Two-period, Cross-over, Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration of the Individual Components in two cohorts of Healthy Chinese Subjects under Fed Conditions
- Study Id
- D1681C00001
- Disease
- diabetes type 2
- Drug Name
- Onglyza
- Study Name
- D1681C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2820 after Administration of Multiple Ascending Doses
- Study Id
- D3870C00002
- Disease
- obesity
- Drug Name
- AstraZeneca Cardiovascular development drugs
- Study Name
- D3870C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
